SlideShare a Scribd company logo
Gleason Score in Prostate Cancer
www.aboutcancer.com
http://aboutcancer.com/videos.htm
https://www.youtube.com/user/robertmillermd/playlists
How Serious is Prostate Cancer?
1. How advanced (stage based on the size
and location of the tumor and possible
spread to nodes or distant sites)
2. How much cancer (how high is the PSA
blood test)
3. How malignant or mutated are the
cancer cells (the grade or Gleason
Score)
Anatomy (where and how advanced)
and Biology (how dangerous are the
cells)
Gleason Grade (or Pattern): a number from 1 to 5 based on how mutated
the cells look under the microscope
Gleason Score: grading at least two areas of the tumor and adding the
numbers together, so score of 2 (1+1) to a maximum of 10 (5+5)
Grade Group: putting the Gleason grade and score into one of five
groups
Confused about Gleason?
Malignant Prostate Cells
All cancer starts as a normal cell that mutates and becomes
malignant
For years, the biology of cancer cells has been
estimated by Pathologists looking at the cells
under a microscope and describing how
mutated the cells look (called the grade)
compared to normal cells.
Eventually this will be replaced by genetic
analysis.
Traditional way to classify malignant
cells.
Prostate Cancer Cure Rate After Radical
Prostatectomy Based on Pathologic Grade
(i.e. how mutated the cancer cells appear)
Cure Rate after Surgery by Grade
Gleason Grade and Scoring System
From the biopsy, the pathologist grades the appearance of the cells. From
least serious (slow growing or Grade 1) to the fastest growing and most
dangerous or grade 5).
The first number is the most common pattern seen from 1 to 5
Gleason Grade and Scoring System
The second number is the next most common pattern seen. Then they add the
two numbers, to get the Gleason Score (e.g. 3+3 or 4+3, etc.)
Gleason Grade and Scoring System
So a 4+3 is more serious than 3+4 even though they both are Gleason 7.
(Since the first number represents the most common pattern).
So the slowest growing cancer has a score of 2 and the fastest (most
dangerous) is a score of 10.
50
55
60
65
70
75
80
85
90
95
6 7 8
5 Year
Survival
10 Year
Survival
The higher the Gleason Score, the lower
the cure rates after surgery
60
65
70
75
80
85
90
95
3+3 3+4 4+4 4+5 5+5
5 year cure rate radiation
radiation plus hormones
The higher the Gleason Score, the lower
the cure rates after radiation
Adding hormone
therapy (e.g. Lupron)
improves the
outcome with
radiation esp. for
High Gleason
cancers
Gleason Grade (or Pattern): a number from 1 to 5 based on how mutated
the cells look under the microscope
Gleason Score: grading at least two areas of the tumor and adding the
numbers together, so score of 2 (1+1) to a maximum of 10 (5+5)
Grade Group: putting the Gleason grade and score into one of five
groups
Confused about Gleason?
Gleason Pattern leads to Gleason Score and now Grade Group
Gleason Pattern Gleason Score Grade Group
3+3 6 1
3+4 7 2
4+3 7 3
4+4 (5+3) 8 4
4+5 or 5+5 9, 10 5
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Group 1 Group 2 Group 3 Group 4 Group 5
Relapse Free Rate at 5 Years after
Surgery
Based on Grade Groups
Eur Urol 2016 Mar;69(3):428-35.
The larger the Group Number the more Serious the Cancer
The larger the group
number, the lower the
cure rate
The AJCC Prognostic Groups now includes Grade Group
Need to know the
grade group to
complete the
stage
The NCCN Risk Groups also are
also based on the Gleason Grade
Group.
The more high risk, the more
important is treatment.
Knowing the Gleason Score Prior to Treatment
1.Will predict the risk that the cancer has
already spread (to other structures of lymph
nodes)
2.Will predict the risk of a relapse (either PSA
relapse or actual spread to bone)
3.Will predict the risk of ever dying of prostate
cancer
aboutcancer.com/medical_calculators
You can go on line and plug in the PSA or
Gleason and see what the likelihood of
spread or relapse would be
Assuming a 60 yo man with 3 + biopsies and a PSA of 6
Estimated Probability of the Results of Surgery Based on Gleason
Gleason Score 3+3 4+3 4+4
Organ confined disease 40% 24% 17%
Extra capsular spread 60% 74% 81%
Lymph Node spread 3% 15% 27%
Seminal Vesicle invasion 3% 12% 23%
Using the Gleason Score to Predict the Outcome of Surgery
http://urology.jhu.edu/prostate/resources3.php
Calculate the risk of a PSA relapse by 10 Years for T2a Patient
Gleason PSA 4-10 PSA 10-20 PSA
>20
6 2% 13% 25%
7 (3+4) 4% 21% 35%
7 (4+3) 8% 26% 47%
8-10 37% 37% 61%
Calculate the Risk of a Relapse (PSA recurrence) after surgery and the
Risk of Dying of Prostate Cancer
Assume 60 yo man, PSA 10, path only extra-capsular extension)
Gleason Relapse Rate by 10 Years Dying of Prostate Cancer by
15 Years
3+3 13% 1%
3+4 24% 2%
4+3 53% 3%
4+4 71% 8%
Calculate the Risk of a Relapse (PSA recurrence) after surgery and the
Risk of Dying of Prostate Cancer
Assume 60 yo man, PSA 25, path only extra-capsular extension)
Gleason Relapse Rate by 10 Years Dying of Prostate Cancer by
15 Years
3+3 21% (13%) 1%
3+4 37% (24%) 2%
4+3 66% (53%) 3%
4+4 80% (71%) 8%
Calculate the Risk of a Relapse (PSA recurrence) after surgery and the
Risk of Dying of Prostate Cancer
Assume 60 yo man, PSA 25, path: extra-capsular extension, also
seminal vesicle invasion and lymph node spread
Gleason Dying of Prostate Cancer by 15 Years
3+3 2% (1%)
3+4 7% (2%)
4+3 12% (3%)
4+4 36% (8%)
Genomic test evaluates the activity of genes in
the tumor that are shown to be involved in the
development and progression of prostate cancer.
Decipher Biopsy
Development and
Validation of a Novel
Integrated Clinical-
Genomic Risk Group
Classification for
Localized Prostate Cancer
New scoring system
that combined the
NNCN with Decipher
Score
Spratt Journal of Clinical
Oncology 36, no. 6, 2018
Development and
Validation of a Novel
Integrated Clinical-
Genomic Risk Group
Classification for
Localized Prostate Cancer
New scoring system
that combined the
NNCN with Decipher
Score
Spratt Journal of Clinical
Oncology 36, no. 6, 2018
Risk of Prostate Specific Mortality
using Combined System
10 Year Risk of Mortality
Low Risk
2%
Intermediate 10.7%
High Risk
27.3%
Spratt Journal of Clinical
Oncology 36, no. 6, 2018
How Serious is Prostate Cancer?
1. How advanced (stage based on the size
and location of the tumor and possible
spread to nodes or distant sites)
2. How much cancer (how high is the PSA
blood test)
3. How malignant or mutated are the
cancer cells (the grade or Gleason
Score) or the Genetic Analysis
(Genomics)
Anatomy (where and how advanced)
and Biology (how dangerous are the
cells)
Cancer Genetics
www.aboutcancer.com
http://aboutcancer.com/videos.htm
https://www.youtube.com/user/robertmillermd/playlists

More Related Content

What's hot

Molecular profiling of breast cancer
Molecular profiling of breast cancerMolecular profiling of breast cancer
Molecular profiling of breast cancer
Hriman Sharma Sarkar
 
Molecular subtypes of breast cancer
Molecular subtypes of breast cancerMolecular subtypes of breast cancer
Molecular subtypes of breast cancerJoydeep Ghosh
 
Sentinel lymph node breast ca
Sentinel lymph node breast caSentinel lymph node breast ca
Sentinel lymph node breast ca
Pannaga Kumar
 
Bethesda Cervical CYtology
Bethesda Cervical CYtologyBethesda Cervical CYtology
Bethesda Cervical CYtology
Sansar Babu Tiwari
 
PROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREAST
PROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREASTPROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREAST
PROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREAST
DrAnkitaPatel
 
Lynch syndrome
Lynch syndromeLynch syndrome
Lynch syndrome
Arthur Greenwood
 
Management Of Testicular Tumours
Management Of Testicular TumoursManagement Of Testicular Tumours
Management Of Testicular Tumoursfondas vakalis
 
gastrointestinal Neuro endocrine tumors , GIT NET
gastrointestinal Neuro endocrine tumors , GIT NETgastrointestinal Neuro endocrine tumors , GIT NET
gastrointestinal Neuro endocrine tumors , GIT NET
Gebrekirstos Hagos Gebrekirstos, MD
 
Molecular diagnostics of colorectal cancer
Molecular diagnostics   of colorectal cancerMolecular diagnostics   of colorectal cancer
Molecular diagnostics of colorectal cancer
Addisu Alemu
 
IHC in breast CA
IHC in breast CAIHC in breast CA
IHC in breast CA
Ashutosh Mukherji
 
Cancer and ihc markers
Cancer and ihc markersCancer and ihc markers
Cancer and ihc markers
Nilesh Kucha
 
Germ cell tumors of ovary
Germ cell tumors of ovaryGerm cell tumors of ovary
Germ cell tumors of ovary
ashish223
 
Treatment of CA Ovary
Treatment of CA OvaryTreatment of CA Ovary
Treatment of CA Ovary
Anil Gupta
 
Recent advances in colorectal carcinoma
Recent advances in colorectal carcinomaRecent advances in colorectal carcinoma
Recent advances in colorectal carcinoma
Vikash Prasad
 
Colorectal Carcinoma Recent Advances.
Colorectal Carcinoma   Recent Advances.Colorectal Carcinoma   Recent Advances.
Colorectal Carcinoma Recent Advances.
Evith Pereira
 
Neuroendocrine Tumors in 2019
Neuroendocrine Tumors in 2019Neuroendocrine Tumors in 2019
Neuroendocrine Tumors in 2019
Mohamed Abdulla
 
Hormonal therapy in breast cancer
Hormonal therapy in breast cancerHormonal therapy in breast cancer
Hormonal therapy in breast cancer
DrAyush Garg
 
DCIS Breast Cancer
DCIS Breast CancerDCIS Breast Cancer
DCIS Breast Cancer
Robert J Miller MD
 
Tumor markers
Tumor markersTumor markers
Tumor markers
Sreekanth Nallam
 
Peritoneal Carcinomatosis : Dr Amit Dangi
Peritoneal Carcinomatosis :  Dr Amit DangiPeritoneal Carcinomatosis :  Dr Amit Dangi
Peritoneal Carcinomatosis : Dr Amit Dangi
Dr Amit Dangi
 

What's hot (20)

Molecular profiling of breast cancer
Molecular profiling of breast cancerMolecular profiling of breast cancer
Molecular profiling of breast cancer
 
Molecular subtypes of breast cancer
Molecular subtypes of breast cancerMolecular subtypes of breast cancer
Molecular subtypes of breast cancer
 
Sentinel lymph node breast ca
Sentinel lymph node breast caSentinel lymph node breast ca
Sentinel lymph node breast ca
 
Bethesda Cervical CYtology
Bethesda Cervical CYtologyBethesda Cervical CYtology
Bethesda Cervical CYtology
 
PROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREAST
PROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREASTPROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREAST
PROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREAST
 
Lynch syndrome
Lynch syndromeLynch syndrome
Lynch syndrome
 
Management Of Testicular Tumours
Management Of Testicular TumoursManagement Of Testicular Tumours
Management Of Testicular Tumours
 
gastrointestinal Neuro endocrine tumors , GIT NET
gastrointestinal Neuro endocrine tumors , GIT NETgastrointestinal Neuro endocrine tumors , GIT NET
gastrointestinal Neuro endocrine tumors , GIT NET
 
Molecular diagnostics of colorectal cancer
Molecular diagnostics   of colorectal cancerMolecular diagnostics   of colorectal cancer
Molecular diagnostics of colorectal cancer
 
IHC in breast CA
IHC in breast CAIHC in breast CA
IHC in breast CA
 
Cancer and ihc markers
Cancer and ihc markersCancer and ihc markers
Cancer and ihc markers
 
Germ cell tumors of ovary
Germ cell tumors of ovaryGerm cell tumors of ovary
Germ cell tumors of ovary
 
Treatment of CA Ovary
Treatment of CA OvaryTreatment of CA Ovary
Treatment of CA Ovary
 
Recent advances in colorectal carcinoma
Recent advances in colorectal carcinomaRecent advances in colorectal carcinoma
Recent advances in colorectal carcinoma
 
Colorectal Carcinoma Recent Advances.
Colorectal Carcinoma   Recent Advances.Colorectal Carcinoma   Recent Advances.
Colorectal Carcinoma Recent Advances.
 
Neuroendocrine Tumors in 2019
Neuroendocrine Tumors in 2019Neuroendocrine Tumors in 2019
Neuroendocrine Tumors in 2019
 
Hormonal therapy in breast cancer
Hormonal therapy in breast cancerHormonal therapy in breast cancer
Hormonal therapy in breast cancer
 
DCIS Breast Cancer
DCIS Breast CancerDCIS Breast Cancer
DCIS Breast Cancer
 
Tumor markers
Tumor markersTumor markers
Tumor markers
 
Peritoneal Carcinomatosis : Dr Amit Dangi
Peritoneal Carcinomatosis :  Dr Amit DangiPeritoneal Carcinomatosis :  Dr Amit Dangi
Peritoneal Carcinomatosis : Dr Amit Dangi
 

Similar to Prostate Cancer and Gleason Score

Prostate video 1
Prostate video 1Prostate video 1
Prostate video 1
Robert J Miller MD
 
Deciding on treatment for prostate cancer 2018
Deciding on treatment for prostate cancer 2018Deciding on treatment for prostate cancer 2018
Deciding on treatment for prostate cancer 2018
Robert J Miller MD
 
Prostate cancer 2018: A brief overview
Prostate cancer 2018: A brief overviewProstate cancer 2018: A brief overview
Prostate cancer 2018: A brief overview
Zeena Nackerdien
 
Screening for prostate cancer 2018
Screening for prostate cancer 2018Screening for prostate cancer 2018
Screening for prostate cancer 2018
Robert J Miller MD
 
CES2019-02: Cáncer de próstata - visión del oncólogo
CES2019-02: Cáncer de próstata - visión del oncólogoCES2019-02: Cáncer de próstata - visión del oncólogo
CES2019-02: Cáncer de próstata - visión del oncólogo
Mauricio Lema
 
Prolaris presentation in Greece 2014
Prolaris presentation in Greece 2014Prolaris presentation in Greece 2014
Prolaris presentation in Greece 2014
Marc Laniado
 
Prostate Cancer - Current Approach and Future Perspective in Castration-Resis...
Prostate Cancer - Current Approach and Future Perspective in Castration-Resis...Prostate Cancer - Current Approach and Future Perspective in Castration-Resis...
Prostate Cancer - Current Approach and Future Perspective in Castration-Resis...
KCR
 
Prostate cancer - Vincent Batista Lemaire
Prostate cancer - Vincent Batista LemaireProstate cancer - Vincent Batista Lemaire
Prostate cancer - Vincent Batista Lemaire
Niela Valdez
 
Breast cancer staging 2018 video power points
Breast cancer staging 2018 video power pointsBreast cancer staging 2018 video power points
Breast cancer staging 2018 video power points
Robert J Miller MD
 
CES202001_CaProstata
CES202001_CaProstataCES202001_CaProstata
CES202001_CaProstata
Mauricio Lema
 
Cancer screening for seniors
Cancer screening for seniorsCancer screening for seniors
Cancer screening for seniors
Robert J Miller MD
 
Prostate cancer modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Prostate cancer   modernising the diagnostic pathway 2013-06-11 by Marc LaniadoProstate cancer   modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Prostate cancer modernising the diagnostic pathway 2013-06-11 by Marc LaniadoMarc Laniado
 
pca screening.pdf
pca screening.pdfpca screening.pdf
pca screening.pdf
ssusere131b1
 
ca prostate by Dr. Musaib Mushtaq.ppt
ca prostate by Dr. Musaib Mushtaq.pptca prostate by Dr. Musaib Mushtaq.ppt
ca prostate by Dr. Musaib Mushtaq.ppt
MusaibMushtaq
 
Genetic assays in breast cancer
Genetic assays in breast cancerGenetic assays in breast cancer
Genetic assays in breast cancer
Vibhay Pareek
 
Evolving recommendations in prostate cancer screening
Evolving recommendations in prostate cancer screeningEvolving recommendations in prostate cancer screening
Evolving recommendations in prostate cancer screening
summer elmorshidy
 
Prostate imaging
Prostate imagingProstate imaging
Prostate imaging
MiadAlsulami
 
NY Prostate Cancer Conference - J.A. Eastham - Session 8: Debate 3: Clinical ...
NY Prostate Cancer Conference - J.A. Eastham - Session 8: Debate 3: Clinical ...NY Prostate Cancer Conference - J.A. Eastham - Session 8: Debate 3: Clinical ...
NY Prostate Cancer Conference - J.A. Eastham - Session 8: Debate 3: Clinical ...European School of Oncology
 
Prostate video 2
Prostate video 2Prostate video 2
Prostate video 2
Robert J Miller MD
 
Screening for carcinoma prostate
Screening for carcinoma prostateScreening for carcinoma prostate
Screening for carcinoma prostatePrakash Hs
 

Similar to Prostate Cancer and Gleason Score (20)

Prostate video 1
Prostate video 1Prostate video 1
Prostate video 1
 
Deciding on treatment for prostate cancer 2018
Deciding on treatment for prostate cancer 2018Deciding on treatment for prostate cancer 2018
Deciding on treatment for prostate cancer 2018
 
Prostate cancer 2018: A brief overview
Prostate cancer 2018: A brief overviewProstate cancer 2018: A brief overview
Prostate cancer 2018: A brief overview
 
Screening for prostate cancer 2018
Screening for prostate cancer 2018Screening for prostate cancer 2018
Screening for prostate cancer 2018
 
CES2019-02: Cáncer de próstata - visión del oncólogo
CES2019-02: Cáncer de próstata - visión del oncólogoCES2019-02: Cáncer de próstata - visión del oncólogo
CES2019-02: Cáncer de próstata - visión del oncólogo
 
Prolaris presentation in Greece 2014
Prolaris presentation in Greece 2014Prolaris presentation in Greece 2014
Prolaris presentation in Greece 2014
 
Prostate Cancer - Current Approach and Future Perspective in Castration-Resis...
Prostate Cancer - Current Approach and Future Perspective in Castration-Resis...Prostate Cancer - Current Approach and Future Perspective in Castration-Resis...
Prostate Cancer - Current Approach and Future Perspective in Castration-Resis...
 
Prostate cancer - Vincent Batista Lemaire
Prostate cancer - Vincent Batista LemaireProstate cancer - Vincent Batista Lemaire
Prostate cancer - Vincent Batista Lemaire
 
Breast cancer staging 2018 video power points
Breast cancer staging 2018 video power pointsBreast cancer staging 2018 video power points
Breast cancer staging 2018 video power points
 
CES202001_CaProstata
CES202001_CaProstataCES202001_CaProstata
CES202001_CaProstata
 
Cancer screening for seniors
Cancer screening for seniorsCancer screening for seniors
Cancer screening for seniors
 
Prostate cancer modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Prostate cancer   modernising the diagnostic pathway 2013-06-11 by Marc LaniadoProstate cancer   modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Prostate cancer modernising the diagnostic pathway 2013-06-11 by Marc Laniado
 
pca screening.pdf
pca screening.pdfpca screening.pdf
pca screening.pdf
 
ca prostate by Dr. Musaib Mushtaq.ppt
ca prostate by Dr. Musaib Mushtaq.pptca prostate by Dr. Musaib Mushtaq.ppt
ca prostate by Dr. Musaib Mushtaq.ppt
 
Genetic assays in breast cancer
Genetic assays in breast cancerGenetic assays in breast cancer
Genetic assays in breast cancer
 
Evolving recommendations in prostate cancer screening
Evolving recommendations in prostate cancer screeningEvolving recommendations in prostate cancer screening
Evolving recommendations in prostate cancer screening
 
Prostate imaging
Prostate imagingProstate imaging
Prostate imaging
 
NY Prostate Cancer Conference - J.A. Eastham - Session 8: Debate 3: Clinical ...
NY Prostate Cancer Conference - J.A. Eastham - Session 8: Debate 3: Clinical ...NY Prostate Cancer Conference - J.A. Eastham - Session 8: Debate 3: Clinical ...
NY Prostate Cancer Conference - J.A. Eastham - Session 8: Debate 3: Clinical ...
 
Prostate video 2
Prostate video 2Prostate video 2
Prostate video 2
 
Screening for carcinoma prostate
Screening for carcinoma prostateScreening for carcinoma prostate
Screening for carcinoma prostate
 

More from Robert J Miller MD

2022 Radiation for Common Cancers
2022 Radiation for Common Cancers2022 Radiation for Common Cancers
2022 Radiation for Common Cancers
Robert J Miller MD
 
Understanding advance directives
Understanding advance directivesUnderstanding advance directives
Understanding advance directives
Robert J Miller MD
 
What’s new in prostate cancer part 2, 2021
What’s new in prostate cancer part 2, 2021What’s new in prostate cancer part 2, 2021
What’s new in prostate cancer part 2, 2021
Robert J Miller MD
 
What’s new in prostate cancer part 1, 2021
What’s new in prostate cancer part 1, 2021What’s new in prostate cancer part 1, 2021
What’s new in prostate cancer part 1, 2021
Robert J Miller MD
 
Smoking and lung cancer and now Covid
Smoking and lung cancer and now CovidSmoking and lung cancer and now Covid
Smoking and lung cancer and now Covid
Robert J Miller MD
 
Music and Aging
Music and AgingMusic and Aging
Music and Aging
Robert J Miller MD
 
Breast cancer 2021
Breast cancer 2021Breast cancer 2021
Breast cancer 2021
Robert J Miller MD
 
Viruses and cancer
Viruses and cancerViruses and cancer
Viruses and cancer
Robert J Miller MD
 
Cancer genetics
Cancer geneticsCancer genetics
Cancer genetics
Robert J Miller MD
 
How we eat affects our health
How we eat affects our healthHow we eat affects our health
How we eat affects our health
Robert J Miller MD
 
Cancer imaging
Cancer imagingCancer imaging
Cancer imaging
Robert J Miller MD
 
Happiness in a pandemic
Happiness in a pandemicHappiness in a pandemic
Happiness in a pandemic
Robert J Miller MD
 
Cancer prevention aspec
Cancer prevention aspecCancer prevention aspec
Cancer prevention aspec
Robert J Miller MD
 
Cancer imaging
Cancer imagingCancer imaging
Cancer imaging
Robert J Miller MD
 
Using the internet to get smarter
Using the internet to get smarterUsing the internet to get smarter
Using the internet to get smarter
Robert J Miller MD
 
Oropharynx cancer and HPV in 2019
Oropharynx cancer and HPV in 2019Oropharynx cancer and HPV in 2019
Oropharynx cancer and HPV in 2019
Robert J Miller MD
 
Cancer prevention
Cancer preventionCancer prevention
Cancer prevention
Robert J Miller MD
 
Radiosurgery for brain metastases
Radiosurgery for brain metastasesRadiosurgery for brain metastases
Radiosurgery for brain metastases
Robert J Miller MD
 
Happiness
HappinessHappiness
Radiosurgery for lung cancer short version
Radiosurgery for lung cancer short versionRadiosurgery for lung cancer short version
Radiosurgery for lung cancer short version
Robert J Miller MD
 

More from Robert J Miller MD (20)

2022 Radiation for Common Cancers
2022 Radiation for Common Cancers2022 Radiation for Common Cancers
2022 Radiation for Common Cancers
 
Understanding advance directives
Understanding advance directivesUnderstanding advance directives
Understanding advance directives
 
What’s new in prostate cancer part 2, 2021
What’s new in prostate cancer part 2, 2021What’s new in prostate cancer part 2, 2021
What’s new in prostate cancer part 2, 2021
 
What’s new in prostate cancer part 1, 2021
What’s new in prostate cancer part 1, 2021What’s new in prostate cancer part 1, 2021
What’s new in prostate cancer part 1, 2021
 
Smoking and lung cancer and now Covid
Smoking and lung cancer and now CovidSmoking and lung cancer and now Covid
Smoking and lung cancer and now Covid
 
Music and Aging
Music and AgingMusic and Aging
Music and Aging
 
Breast cancer 2021
Breast cancer 2021Breast cancer 2021
Breast cancer 2021
 
Viruses and cancer
Viruses and cancerViruses and cancer
Viruses and cancer
 
Cancer genetics
Cancer geneticsCancer genetics
Cancer genetics
 
How we eat affects our health
How we eat affects our healthHow we eat affects our health
How we eat affects our health
 
Cancer imaging
Cancer imagingCancer imaging
Cancer imaging
 
Happiness in a pandemic
Happiness in a pandemicHappiness in a pandemic
Happiness in a pandemic
 
Cancer prevention aspec
Cancer prevention aspecCancer prevention aspec
Cancer prevention aspec
 
Cancer imaging
Cancer imagingCancer imaging
Cancer imaging
 
Using the internet to get smarter
Using the internet to get smarterUsing the internet to get smarter
Using the internet to get smarter
 
Oropharynx cancer and HPV in 2019
Oropharynx cancer and HPV in 2019Oropharynx cancer and HPV in 2019
Oropharynx cancer and HPV in 2019
 
Cancer prevention
Cancer preventionCancer prevention
Cancer prevention
 
Radiosurgery for brain metastases
Radiosurgery for brain metastasesRadiosurgery for brain metastases
Radiosurgery for brain metastases
 
Happiness
HappinessHappiness
Happiness
 
Radiosurgery for lung cancer short version
Radiosurgery for lung cancer short versionRadiosurgery for lung cancer short version
Radiosurgery for lung cancer short version
 

Recently uploaded

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 

Recently uploaded (20)

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 

Prostate Cancer and Gleason Score

  • 1. Gleason Score in Prostate Cancer
  • 3. How Serious is Prostate Cancer? 1. How advanced (stage based on the size and location of the tumor and possible spread to nodes or distant sites) 2. How much cancer (how high is the PSA blood test) 3. How malignant or mutated are the cancer cells (the grade or Gleason Score) Anatomy (where and how advanced) and Biology (how dangerous are the cells)
  • 4. Gleason Grade (or Pattern): a number from 1 to 5 based on how mutated the cells look under the microscope Gleason Score: grading at least two areas of the tumor and adding the numbers together, so score of 2 (1+1) to a maximum of 10 (5+5) Grade Group: putting the Gleason grade and score into one of five groups Confused about Gleason?
  • 5. Malignant Prostate Cells All cancer starts as a normal cell that mutates and becomes malignant
  • 6. For years, the biology of cancer cells has been estimated by Pathologists looking at the cells under a microscope and describing how mutated the cells look (called the grade) compared to normal cells. Eventually this will be replaced by genetic analysis. Traditional way to classify malignant cells.
  • 7. Prostate Cancer Cure Rate After Radical Prostatectomy Based on Pathologic Grade (i.e. how mutated the cancer cells appear) Cure Rate after Surgery by Grade
  • 8.
  • 9. Gleason Grade and Scoring System From the biopsy, the pathologist grades the appearance of the cells. From least serious (slow growing or Grade 1) to the fastest growing and most dangerous or grade 5). The first number is the most common pattern seen from 1 to 5
  • 10. Gleason Grade and Scoring System The second number is the next most common pattern seen. Then they add the two numbers, to get the Gleason Score (e.g. 3+3 or 4+3, etc.)
  • 11. Gleason Grade and Scoring System So a 4+3 is more serious than 3+4 even though they both are Gleason 7. (Since the first number represents the most common pattern). So the slowest growing cancer has a score of 2 and the fastest (most dangerous) is a score of 10.
  • 12. 50 55 60 65 70 75 80 85 90 95 6 7 8 5 Year Survival 10 Year Survival The higher the Gleason Score, the lower the cure rates after surgery
  • 13. 60 65 70 75 80 85 90 95 3+3 3+4 4+4 4+5 5+5 5 year cure rate radiation radiation plus hormones The higher the Gleason Score, the lower the cure rates after radiation Adding hormone therapy (e.g. Lupron) improves the outcome with radiation esp. for High Gleason cancers
  • 14. Gleason Grade (or Pattern): a number from 1 to 5 based on how mutated the cells look under the microscope Gleason Score: grading at least two areas of the tumor and adding the numbers together, so score of 2 (1+1) to a maximum of 10 (5+5) Grade Group: putting the Gleason grade and score into one of five groups Confused about Gleason?
  • 15. Gleason Pattern leads to Gleason Score and now Grade Group Gleason Pattern Gleason Score Grade Group 3+3 6 1 3+4 7 2 4+3 7 3 4+4 (5+3) 8 4 4+5 or 5+5 9, 10 5
  • 16. 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Group 1 Group 2 Group 3 Group 4 Group 5 Relapse Free Rate at 5 Years after Surgery Based on Grade Groups Eur Urol 2016 Mar;69(3):428-35. The larger the Group Number the more Serious the Cancer The larger the group number, the lower the cure rate
  • 17. The AJCC Prognostic Groups now includes Grade Group Need to know the grade group to complete the stage
  • 18. The NCCN Risk Groups also are also based on the Gleason Grade Group. The more high risk, the more important is treatment.
  • 19. Knowing the Gleason Score Prior to Treatment 1.Will predict the risk that the cancer has already spread (to other structures of lymph nodes) 2.Will predict the risk of a relapse (either PSA relapse or actual spread to bone) 3.Will predict the risk of ever dying of prostate cancer
  • 20. aboutcancer.com/medical_calculators You can go on line and plug in the PSA or Gleason and see what the likelihood of spread or relapse would be
  • 21. Assuming a 60 yo man with 3 + biopsies and a PSA of 6 Estimated Probability of the Results of Surgery Based on Gleason Gleason Score 3+3 4+3 4+4 Organ confined disease 40% 24% 17% Extra capsular spread 60% 74% 81% Lymph Node spread 3% 15% 27% Seminal Vesicle invasion 3% 12% 23% Using the Gleason Score to Predict the Outcome of Surgery
  • 22. http://urology.jhu.edu/prostate/resources3.php Calculate the risk of a PSA relapse by 10 Years for T2a Patient Gleason PSA 4-10 PSA 10-20 PSA >20 6 2% 13% 25% 7 (3+4) 4% 21% 35% 7 (4+3) 8% 26% 47% 8-10 37% 37% 61%
  • 23. Calculate the Risk of a Relapse (PSA recurrence) after surgery and the Risk of Dying of Prostate Cancer Assume 60 yo man, PSA 10, path only extra-capsular extension) Gleason Relapse Rate by 10 Years Dying of Prostate Cancer by 15 Years 3+3 13% 1% 3+4 24% 2% 4+3 53% 3% 4+4 71% 8%
  • 24. Calculate the Risk of a Relapse (PSA recurrence) after surgery and the Risk of Dying of Prostate Cancer Assume 60 yo man, PSA 25, path only extra-capsular extension) Gleason Relapse Rate by 10 Years Dying of Prostate Cancer by 15 Years 3+3 21% (13%) 1% 3+4 37% (24%) 2% 4+3 66% (53%) 3% 4+4 80% (71%) 8%
  • 25. Calculate the Risk of a Relapse (PSA recurrence) after surgery and the Risk of Dying of Prostate Cancer Assume 60 yo man, PSA 25, path: extra-capsular extension, also seminal vesicle invasion and lymph node spread Gleason Dying of Prostate Cancer by 15 Years 3+3 2% (1%) 3+4 7% (2%) 4+3 12% (3%) 4+4 36% (8%)
  • 26. Genomic test evaluates the activity of genes in the tumor that are shown to be involved in the development and progression of prostate cancer.
  • 28.
  • 29. Development and Validation of a Novel Integrated Clinical- Genomic Risk Group Classification for Localized Prostate Cancer New scoring system that combined the NNCN with Decipher Score Spratt Journal of Clinical Oncology 36, no. 6, 2018
  • 30. Development and Validation of a Novel Integrated Clinical- Genomic Risk Group Classification for Localized Prostate Cancer New scoring system that combined the NNCN with Decipher Score Spratt Journal of Clinical Oncology 36, no. 6, 2018
  • 31. Risk of Prostate Specific Mortality using Combined System 10 Year Risk of Mortality Low Risk 2% Intermediate 10.7% High Risk 27.3% Spratt Journal of Clinical Oncology 36, no. 6, 2018
  • 32. How Serious is Prostate Cancer? 1. How advanced (stage based on the size and location of the tumor and possible spread to nodes or distant sites) 2. How much cancer (how high is the PSA blood test) 3. How malignant or mutated are the cancer cells (the grade or Gleason Score) or the Genetic Analysis (Genomics) Anatomy (where and how advanced) and Biology (how dangerous are the cells) Cancer Genetics